Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Un estudio realizado en un grupo de mexicano-estadounidenses de 40 años o más determinó que la tasa de diabetes en este grupo es del 20 por ciento (tasa casi dos veces mayor que la correspondiente a blancos no hispanos) y que el 15 por ciento de las...
Two groups of researchers have found no association between nighttime light exposure during sleep in the first two years of life and the subsequent development of nearsightedness, or myopia.
Modest supplemental oxygen given to premature infants with moderate cases of retinopathy of prematurity (ROP), a potentially blinding eye disorder, may not significantly improve ROP, but definitely does not make it worse, according to researchers funded
Researchers at Teachers College, Columbia University and Albert Einstein College of Medicine have determined that health education programs can substantially increase the rates of dilated eye exams for African Americans with diabetes
A combination of anti-HIV drugs appears to help rejuvenate the immune systems of people with AIDS and prevent progression of cytomegalovirus (CMV) retinitis, a potentially blinding AIDS-related eye complication.
Patient recruitment has begun on a clinical trial to find out if laser treatment decreases vision loss for people who may be at risk for severe age-related macular degeneration (AMD).
In a small preliminary study, researchers at the National Institutes of Health (NIH) have discovered a possible new treatment for uveitis, a potentially blinding eye disease.
Researchers have found that an antiviral drug, often used to suppress genital herpes, also decreases the recurrence of herpes of the eye. A paper detailing these findings is published in the July 30, 1998 issue of The New England Journal of Medicine
Researchers supported by the National Institutes of Health have discovered that black and white patients with advanced glaucoma respond differently to two surgical treatments for the disease. A paper detailing these findings is published in the July 1998